Premium
Immunotherapy in lung cancer
Author(s) -
Bravo Montenegro Gabriela,
Farid Saira,
Liu Stephen V.
Publication year - 2021
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.26347
Subject(s) - medicine , immunotherapy , lung cancer , disease , monoclonal antibody , oncology , cancer , radiation therapy , stage (stratigraphy) , lung , surgery , intensive care medicine , immunology , antibody , paleontology , biology
Abstract Immunotherapy has emerged as an important treatment modality throughout oncology with a particularly important role in the treatment of lung cancer. Early signals showed responses could be achieved in nonsmall cell lung cancer and small cell lung cancer and these monoclonal antibodies have become standards of care for advanced stage disease. They have also shown promise in earlier‐stage disease as complements to radiation or surgery, offering the potential for durable, meaningful survival gains.